Calithera Biosciences Funding: $40M Raised, Series A (2024)

Calithera Biosciences is a Biotech company based in South San Francisco. It has raised $40M in total funding. Latest round: Series A.

Calithera Biosciences funding overview

Calithera Biosciences is a Biotech company based in South San Francisco. Calithera Biosciences has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Calithera Biosciences runs through 2024; nothing later has been disclosed. Investors on record include Morgenthaler Ventures, U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures, Mission Bay Capital. 5 distinct backers are named across the disclosed rounds.

Calithera Biosciences at a glance

Total raised
$40M
Latest round
Series A
Latest round date
July 2024
Industry
Biotech
Headquarters
South San Francisco
Notable investors
Morgenthaler Ventures, U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures, Mission Bay Capital

Frequently asked about Calithera Biosciences funding

How much has Calithera Biosciences raised?
Calithera Biosciences has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Calithera Biosciences?
Morgenthaler Ventures, U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures, Mission Bay Capital are named among the investors backing Calithera Biosciences.
What was the latest Calithera Biosciences funding round?
The most recent disclosed round is a Series A, announced in July 2024.
Where is Calithera Biosciences based?
Calithera Biosciences is based in South San Francisco.
What sector does Calithera Biosciences operate in?
Calithera Biosciences is tracked under Biotech from South San Francisco, with $40M in disclosed funding.
When did Calithera Biosciences last raise?
The last disclosed Calithera Biosciences round closed in July 2024 at Series A.

Calithera Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in South San Francisco below to benchmark round size and investor mix.

Calithera Biosciences founders (1)

Companies related to Calithera Biosciences (40)

Browse related funding lists (4)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades